Advertisement
Screener

Septerna, Inc. (SEPN) EBITDA

Septerna, Inc. (SEPN) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$16.44M; Operating income (m); Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA -$12.9M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$15.62M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA $3.01M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2023-09-30 to 2026-06-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$16.44M(m)(m)(m)-61.45%$0.00*-$22.18M*(m)$35.13M(m)$973.00K
2026-03-31Reported-$12.9M(m)(m)(m)-48.64%$832.00K-$25.63M(m)$29.54M(m)$337.00K
2025-12-31Reported-$15.62M(m)(m)(m)-64.78%(m)(m)(m)(m)(m)(m)
2025-09-30Reported$3.01M(m)(m)(m)14.02%$13.00K*$168.81M*(m)$24.26M(m)$0.00
2025-06-30Reported-$28.58M(m)(m)(m)-24015.13%$58.00K*-$20.29M*(m)$22.19M(m)$0.00
2025-03-31Reported-$25.51M(m)(m)(m)-11648.40%$382.00K-$23.34M(m)$19.27M(m)$0.00
2024-12-31Reported-$24.32M(m)(m)(m)-11470.75%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$22.15M(m)(m)(m)-12585.23%$578.00K*-$16.81M*(m)$17.83M(m)-$136.00K
2024-06-30Reported-$17.77M(m)(m)(m)-4801.35%$149.00K*-$12.99M*(m)$15.04M(m)$109.00K
2024-03-31Reported-$15.19M(m)(m)(m)-4791.80%$764.00K-$16.71M(m)$13.15M(m)$93.00K
2023-12-31Reported$34.52M(m)(m)(m)29251.69%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$11.84M(m)(m)(m)-35878.79%(m)(m)(m)$9.28M(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$66.7M(m)(m)(m)-145.15%$518.00K$110.19M(m)$97.58M(m)$12.00K
2024-12-31Reported-$79.42M(m)(m)(m)-7388.19%$2.10M-$67.47M(m)$65.34M(m)-$498.00K
2023-12-31Reported$2.88M(m)(m)(m)1903.97%$2.88M-$38.72M(m)$35.98M(m)$691.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Xencor Inc (XNCR)United States$1.776B-7.33
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77
COMPASS Pathways plc (CMPS)$1.812B-4.87
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82